Search Results
Found 1 results
510(k) Data Aggregation
(87 days)
Injector used for the subcutaneous administrations of xylocaine or calcimar/calcitonin which are appropriate for subcutaneous injection using jet injection or needleless injection systems. For subcutaneous injections only. The device serves as an alternative to the subcutaneous delivery of xylocaine or calcimar/calcitonin medications with needle and syringe.
J-Tip Needleless Injection System
This document is a 510(k) premarket notification decision letter from the FDA regarding the "J-Tip Needleless Injection System". It primarily focuses on regulatory approval and does not contain information about acceptance criteria or a study proving device performance in the manner requested.
Therefore, I cannot provide the detailed information about acceptance criteria and a performance study based on this document. The document confirms that the device is "substantially equivalent" to previously marketed devices, which is a regulatory determination, not a clinical performance validation against specific acceptance criteria.
Ask a specific question about this device
Page 1 of 1